Holen Sie sich die Stockscreener-App
4.35
3.12%
-0.14
Handel nachbörslich:
4.34
-0.010
-0.23%
Schlusskurs vom Vortag:
$4.49
Offen:
$4.72
24-Stunden-Volumen:
205.04K
Relative Volume:
1.13
Marktkapitalisierung:
$156.87M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-2.1987
EPS:
-1.9784
Netto-Cashflow:
-
1W Leistung:
-16.83%
1M Leistung:
+0.93%
6M Leistung:
-1.81%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.17
$4.72
1-Wochen-Bereich:
$4.17
$5.15
52-Wochen-Spanne:
$2.34
$8.79
Anteris Technologies Global Corp Stock (AVR) Company Profile
Firmenname
Anteris Technologies Global Corp
Sektor
Telefon
651-493-0606
Adresse
860 BLUE GENTIAN ROAD, EAGAN
Vergleichen Sie AVR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
4.35 | 161.92M | 0 | 0 | 0 | -1.9784 |
|
ISRG
Intuitive Surgical Inc
|
544.21 | 189.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
177.30 | 51.22B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.88 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
248.95 | 36.04B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
279.78 | 20.29B | 2.96B | 487.70M | 344.00M | 6.6758 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-08 | Eingeleitet | Lake Street | Buy |
| 2025-01-07 | Eingeleitet | Barclays | Overweight |
| 2025-01-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-01-07 | Eingeleitet | TD Cowen | Buy |
Anteris Technologies Global Corp Aktie (AVR) Neueste Nachrichten
Anteris Technologies: Strategic Advancements and FDA Approval Bolster Buy Rating - TipRanks
Anteris Technologies Global Corp. stock momentum explainedJuly 2025 WrapUp & Weekly Watchlist of Top Performers - newser.com
Anteris Technologies Secures FDA Approval for Global PARADIGM Trial - MSN
Will Anteris Technologies Global Corp. see short term momentum - newser.com
Anteris Technologies Receives FDA Approval for PARADIGM Trial - TipRanks
Anteris Technologies Global Corp FDA Approval for PARADIGM Trial - TradingView
Detecting price anomalies in Anteris Technologies Global Corp. with AIJuly 2025 Price Swings & Accurate Trade Setup Notifications - newser.com
What machine learning models say about Anteris Technologies Global Corp.2025 Institutional Moves & Free Weekly Chart Analysis and Trade Guides - newser.com
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the 'PARADIGM Trial”) - The Manila Times
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”) - Stock Titan
Anteris Technologies Initiates Global Trial for Innovative Heart Valve - MSN
Analyzing Anteris Technologies Global Corp. with multi timeframe chartsJuly 2025 Breakouts & Free Verified High Yield Trade Plans - newser.com
Is it time to cut losses on Anteris Technologies Global Corp.2025 Year in Review & Expert Verified Movement Alerts - newser.com
Using data models to predict Anteris Technologies Global Corp. stock movementJuly 2025 Chart Watch & Safe Entry Point Identification - newser.com
Should you wait for a breakout in Anteris Technologies Global Corp.Wall Street Watch & Verified Momentum Watchlists - newser.com
Published on: 2025-11-03 02:48:19 - newser.com
Anteris Technologies Announces Cessation of Securities - TipRanks
Anteris Technologies Updates Capital Raising Timetable - TipRanks
Why Anteris Technologies Global Corp. stock is seen as undervalued - newser.com
Can Anteris Technologies Global Corp. hit a new high this monthQuarterly Trade Report & Safe Entry Zone Tips - newser.com
How rising interest rates impact Anteris Technologies Global Corp. stockWeekly Loss Report & Low Drawdown Investment Ideas - newser.com
Anteris Technologies Receives US FDA Approval for Transcatheter Heart Valve Trial; Shares Up 11% - MarketScreener
Will Anteris Technologies Global Corp. stock continue dividend increasesRecession Risk & Verified Chart Pattern Trade Signals - newser.com
Anteris Technologies Global Corp says FDA approves DurAVR THV global pivotal trial - MarketScreener
Is Anteris Technologies Global Corp. stock a safe buy before earningsGDP Growth & Weekly Market Pulse Updates - newser.com
What does recent volatility data suggest for Anteris Technologies Global Corp.CPI Data & Accurate Entry and Exit Point Alerts - newser.com
How strong is Anteris Technologies Global Corp. stock balance sheet2025 Biggest Moves & Precise Buy Zone Identification - newser.com
Anteris Technologies Global Corp. (AVR.AX) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Anteris Technologies Global Corp. (AVR) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Will Anteris Technologies Global Corp. continue its uptrendSell Signal & Long-Term Safe Investment Ideas - newser.com
Using flow based indicators on Anteris Technologies Global Corp.July 2025 Pullbacks & Short-Term Swing Trade Alerts - newser.com
Combining machine learning predictions for Anteris Technologies Global Corp.Earnings Recap Report & Fast Gaining Stock Reports - newser.com
Anteris Technologies Advances Capital Raising Efforts to Strengthen Market Position - MSN
Weiss Ratings Reaffirms "Sell (D-)" Rating for Anteris Technologies Global (NASDAQ:AVR) - MarketBeat
Price momentum metrics for Anteris Technologies Global Corp. explained2025 Momentum Check & Fast Moving Stock Watchlists - newser.com
Is Anteris Technologies Global Corp. stock bottoming out2025 Price Targets & Verified Chart Pattern Signals - newser.com
Finanzdaten der Anteris Technologies Global Corp-Aktie (AVR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.41%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):